Revenue Recognition

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Revenue Recognition

12.Revenue Recognition

The following table provides information about disaggregated revenue by product and services:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Product sales and rentals, net	$	1,684	$	1,041	$	3,633	$	2,920
Processing and storage fees, net		1,427		1,405		4,062		4,061
License, royalty and other		675		1,689		2,964		6,865
Net revenue	$	3,786	$	4,135	$	10,659	$	13,846

The following table provides changes in deferred revenue from contract liabilities:

	2023			2022
Balance at January 1	$	4,492		$	4,067
Deferral of revenue*		4,579			3,699
Recognition of unearned revenue		(3,514	)		(3,405	)
Balance at September 30	$	5,557		$	4,361

* Deferral of revenue resulted from payments received in advance of performance under the biobanking services storage contracts that are recognized as revenue under the contract as performance is completed. Also includes up-front payment incurred in connection with signing of the Regeneron Services Agreement in August 2023 (see Note 13 below).